WashU announces new academic-industry collaboration with Bristol Myers Squibb
WashU and Bristol Myers Squibb have formed a multiyear collaboration to advance drug development projects in the neurosciences. WashU medical and research trainees will have opportunities to work alongside the company’s scientists at its facilities as part of the agreement.
Dementia rising across Latino populations, multidecade study finds
Research led by WashU Medicine neurologist Jorge Llibre-Guerra, MD, provides the first direct evidence that some parts of Latin America are moving in the opposite direction of dropping dementia rates in the U.S. and other wealthy nations.
DNA damage can trigger neurons to self-destruct
WashU Medicine researchers identified key details of how DNA damage can flip a nerve cell’s self-destruct switch. The new study could lead to novel routes to preventing neurodegeneration in a variety of diseases.
Aid for brain-bleed recovery receives FDA Breakthrough Device Designation
An earbud-like device from Aurenar, a WashU startup, is designed to improve stroke outcomes after a ruptured brain aneurysm. The technology is based on clinical trials led by WashU Medicine physician-scientists including Eric Leuthardt, MD.
Socioeconomic factors linked to lasting imprint in kids’ brains
A study led by WashU Medicine researchers shows that a family’s financial situation and the resources and opportunities in a child’s neighborhood had the strongest connection to brain development, accounting for 16% of the variability in measures of children’s brain function — far more than IQ, parenting style, health history or any other factor.
New research reveals how brains update their predictions
Researchers in Bruce Carlson’s lab at WashU study electric fish to understand the basics of brain sensory processing and prediction.
Light, genetics provide insight into arrhythmia’s effects on brain
WashU biomedical engineers used highly sensitive imaging in a mouse model to better understand arrhythmia’s effect on the brain.
Learning from our ‘priors’
Behavioral science researchers at WashU have gathered evidence on the benefits of using a Bayesian statistical framework for replicating research.
WashU Medicine researchers to build AI tools to boost Alzheimer’s research
A grant of nearly $800,000 will fund the development of an “AI Scientist” system aimed at improving biomedical research efficiency, with an initial focus on neurodegenerative disease.
WashU entrepreneurs and innovators honored
In total, WashU startups received nearly $125,000 in funding during an event at the Skandalaris Center’s annual spring awards ceremony.
Older Stories